• Multisystem granulomatous disease that most commonly involves lymph nodes and lungs
  • 20-60 most common, all ages & genders globally more in smokers and African and North European descent
  • Idiopathetic granulomatous inflammation leading to fibrosis (non-caseating granulommas)
  • Nodal enlargement, resp symptoms, constitutional symptoms (fever fatigue, weight loss, sweats)